Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Emerging Roles of RNA Modifications in Glioblastoma
Zhen Dong, Hongjuan Cui
Cancers (2020) Vol. 12, Iss. 3, pp. 736-736
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

The role of RNA m5C modification in cancer metastasis
Qiaofeng Zhang, Furong Liu, Wei Chen, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 13, pp. 3369-3380
Open Access | Times Cited: 112
N6-methyladenosine and Neurological Diseases
Nan Zhang, Chunhong Ding, Yuxin Zuo, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1925-1937
Closed Access | Times Cited: 100
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 72
RNA methylations in human cancers
Xiao Han, Mengke Wang, Yongliang Zhao, et al.
Seminars in Cancer Biology (2020) Vol. 75, pp. 97-115
Closed Access | Times Cited: 133
RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
Chang Gu, Xin Shi, Chenyang Dai, et al.
The Innovation (2020) Vol. 1, Iss. 3, pp. 100066-100066
Open Access | Times Cited: 95
Transfer RNAs: diversity in form and function
Matthew D. Berg, Christopher J. Brandl
RNA Biology (2020) Vol. 18, Iss. 3, pp. 316-339
Open Access | Times Cited: 85
m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma
Jianyang Du, Hang Ji, Shuai Ma, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 5
Closed Access | Times Cited: 71
Biological and pharmacological roles of m6A modifications in cancer drug resistance
Zaoqu Liu, Haijiao Zou, Qin Dang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 52
An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma
Dongqi Shao, Yu Li, Junyong Wu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 50
tRNA Modifications and Modifying Enzymes in Disease, the Potential Therapeutic Targets
Weifang Cui, Deze Zhao, Junjie Jiang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 4, pp. 1146-1162
Open Access | Times Cited: 24
FTO Suppresses Proliferation and Induces Apoptosis of T98G Glioblastoma Cells via N6-methyladenosine Modification of GSTO1
Jinjiang Dong, J.P. Mao, Weihua Wu, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access | Times Cited: 1
Context-Dependent Roles of RNA Modifications in Stress Responses and Diseases
Emma Wilkinson, Yan‐Hong Cui, Yu‐Ying He
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1949-1949
Open Access | Times Cited: 48
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases
Wanwan Zhou, Xiao Wang, Jun Chang, et al.
Critical Reviews in Clinical Laboratory Sciences (2021) Vol. 59, Iss. 3, pp. 203-218
Closed Access | Times Cited: 47
The N6-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma
Rongrong Zhao, Boyan Li, Shouji Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation
Hai‐Jian Sun, Zhiyuan Wu, Xiaowei Nie, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 6, pp. 868-884
Open Access | Times Cited: 49
RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases
Wanwan Zhou, Changhui Wang, Jun Chang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32
tRNA Function and Dysregulation in Cancer
Tania Gupta, Mark G. Malkin, Suyun Huang
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 22
Constructing a Glioblastoma Prognostic Model Related to Fatty Acid Metabolism Using Machine Learning and Identifying F13A1 as a Potential Target
Yu‐Shu Liu, Hui Deng, Ping Song, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 256-256
Open Access
Pharmacology of Epitranscriptomic Modifications: Decoding the Therapeutic Potential of RNA Modifications in Drug Resistance
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access
Competing Endogenous RNA Networks in Glioma
Liang Cen, Ruochen Liu, Wei Liu, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 32
The role m6A RNA methylation is CNS development and glioma pathogenesis
Ting Pan, Fan Wu, Liwen Li, et al.
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 31
The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance
Shaun Wood, Amber Willbanks, Jason X. Cheng
Current Cancer Drug Targets (2021) Vol. 21, Iss. 4, pp. 326-352
Closed Access | Times Cited: 27
Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
Paramasivam Arumugam, Rinku George, Vijayashree Priyadharsini Jayaseelan
PubMed (2021) Vol. 11, Iss. 7, pp. 3688-3697
Closed Access | Times Cited: 27
METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way
Xuejun Dou, Zhiyuan Wang, Weiqiang Lü, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Deciphering glioma epitranscriptome: focus on RNA modifications
Christina Piperi, Mariam Markouli, Antonios N. Gargalionis, et al.
Oncogene (2023) Vol. 42, Iss. 28, pp. 2197-2206
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top